Correlation Between Amgen and Galecto
Can any of the company-specific risk be diversified away by investing in both Amgen and Galecto at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amgen and Galecto into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amgen Inc and Galecto, you can compare the effects of market volatilities on Amgen and Galecto and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amgen with a short position of Galecto. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amgen and Galecto.
Diversification Opportunities for Amgen and Galecto
Excellent diversification
The 3 months correlation between Amgen and Galecto is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Amgen Inc and Galecto in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Galecto and Amgen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amgen Inc are associated (or correlated) with Galecto. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Galecto has no effect on the direction of Amgen i.e., Amgen and Galecto go up and down completely randomly.
Pair Corralation between Amgen and Galecto
Given the investment horizon of 90 days Amgen Inc is expected to generate 0.16 times more return on investment than Galecto. However, Amgen Inc is 6.07 times less risky than Galecto. It trades about 0.2 of its potential returns per unit of risk. Galecto is currently generating about -0.01 per unit of risk. If you would invest 25,722 in Amgen Inc on December 28, 2024 and sell it today you would earn a total of 4,973 from holding Amgen Inc or generate 19.33% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Amgen Inc vs. Galecto
Performance |
Timeline |
Amgen Inc |
Galecto |
Amgen and Galecto Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Amgen and Galecto
The main advantage of trading using opposite Amgen and Galecto positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amgen position performs unexpectedly, Galecto can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Galecto will offset losses from the drop in Galecto's long position.The idea behind Amgen Inc and Galecto pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Galecto vs. Terns Pharmaceuticals | Galecto vs. Day One Biopharmaceuticals | Galecto vs. Acumen Pharmaceuticals | Galecto vs. Amylyx Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |